Steroid Hormone Receptor and Infiltrating Immune Cell Status Reveals Therapeutic Vulnerabilities of ESR1-Mutant Breast Cancer-Reference-Cited by-同舟云学术

Steroid Hormone Receptor and Infiltrating Immune Cell Status Reveals Therapeutic Vulnerabilities of ESR1-Mutant Breast Cancer

Published:2020-11-12 Issue:3 Volume:81 Page:732-746
ISSN:0008-5472
Container-title:Cancer Research
language:en
Short-container-title:Cancer Res

Author:

Williams Michelle M.^ORCID,Spoelstra Nicole S.,Arnesen Spencer^ORCID,O'Neill Kathleen I.,Christenson Jessica L.^ORCID,Reese Jordan,Torkko Kathleen C.,Goodspeed Andrew,Rosas Emmanuel,Hanamura Toru,Sams Sharon B.,Li Zheqi,Oesterreich Steffi^ORCID,Riggins Rebecca B.,Jacobsen Britta M.^ORCID,Elias Anthony^ORCID,Gertz Jason,Richer Jennifer K.^ORCID

Funder

DOD | United States Army | MEDCOM | Congressionally Directed Medical Research Programs

HHS | NIH | National Cancer Institute

HHS | National Institutes of Health

U.S. Department of Defense

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Estrogen Receptor Alpha Mutations, Truncations, Heterodimers, and Therapies;Endocrinology;2024-04-21

2. Liver tropism of ER mutant breast cancer is characterized by unique molecular changes and immune infiltration;Breast Cancer Research and Treatment;2024-03-01

3. Estrogen Receptor Mutations as Novel Targets for Immunotherapy in Metastatic Estrogen Receptor–positive Breast Cancer;Cancer Research Communications;2024-02-22

4. The clinical impact of plasma estrogen receptor-1 mutation in patients with metastatic breast cancer: A meta-analysis;Advances in Clinical and Experimental Medicine;2024-02-14

5. Interplay between Estrogen, Kynurenine, and AHR Pathways: An immunosuppressive axis with therapeutic potential for breast cancer treatment;Biochemical Pharmacology;2023-11